[lu-177]-pnt2002,abiraterone,enzalutamide
astellas,janssen,pfizer,point biopharma
['crpc', 'splash', 'point bio']
point biopharma provides updated efficacy and safety data from the lead-in cohort of the phase 3 splash trial in mcrpc at esmo congress 2022 #business
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.